IPWatchdog

Publish Date
Celebrating World IP Day: Is the Innovative Future Sustainable?
IPWatchdog
Eileen McDermott
C4IP Releases First Congressional Innovation Scorecard
IPWatchdog
Alec Pronk
Members of Congress Blast Biden on March-In Proposal and Pandemic Accord

A bipartisan group of 28 members of congress, including Senate IP Subcommittee Chair Chris Coons (D-DE), Ranking Member Thom Tillis (R-NC) and...

IPWatchdog
Eileen McDermott
Public Comments Reveal Widespread Unity in Opposition to NIST’s March-In Rights Framework
IPWatchdog
Steve Brachmann
Iancu, Michel and Other PTAB Masters Panelists Float Ways to Make the System Better
IPWatchdog
Eileen McDermott
The March-In Drug Price Control Narrative Crumbles While Its Damage to American Innovation Grows
IPWatchdog
Joe Allen
Witnesses Clash Over Potential Pros and Cons of PERA in Senate IP Subcommittee Hearing
IPWatchdog
Eileen McDermott
The Top U.S. FRAND / RAND Licensing Developments of 2023 Part II: Ghosts of Christmas Past and Christmas Future
IPWatchdog
Curtis Dodd and Chris Dubuc
From AI to Amgen, Here’s Everything IP that Mattered in 2023

Another year of IP is behind us, and it is time to reflect on what mattered most—what decisions will affect practice for...

IPWatchdog
Eileen McDermott
Proposed Framework on March-In Rights Dubbed ‘Unprecedented’ by U.S. Chamber
IPWatchdog
Eileen McDermott
C4IP and IP Celebrities Tell Biden to Pass on Extension of TRIPS Waiver

Nearly 50 former government officials and other well-known figures in the IP space signed onto a letter today penned by the Council...

IPWatchdog
Eileen McDermott
C4IP Expresses Support for Anticounterfeiting Legislation Introduced in the Senate
IPWatchdog
Alec Pronk
News:

News:

Celebrating World IP Day: Is the Innovative Future Sustainable?,

04/26/2024

News:

News:

C4IP Releases First Congressional Innovation Scorecard,

03/22/2024

News:

News:

Members of Congress Blast Biden on March-In Proposal and Pandemic Accord,

02/22/2024

News:

News:

Public Comments Reveal Widespread Unity in Opposition to NIST’s March-In Rights Framework,

02/05/2024

News:

News:

Iancu, Michel and Other PTAB Masters Panelists Float Ways to Make the System Better,

01/30/2024

News:

News:

The March-In Drug Price Control Narrative Crumbles While Its Damage to American Innovation Grows,

01/29/2024

News:

News:

Witnesses Clash Over Potential Pros and Cons of PERA in Senate IP Subcommittee Hearing,

01/23/2024

News:

News:

The Top U.S. FRAND / RAND Licensing Developments of 2023 Part II: Ghosts of Christmas Past and Christmas Future,

12/27/2023

News:

News:

From AI to Amgen, Here’s Everything IP that Mattered in 2023,

12/24/2023

News:

News:

Proposed Framework on March-In Rights Dubbed ‘Unprecedented’ by U.S. Chamber,

12/07/2023

News:

News:

C4IP and IP Celebrities Tell Biden to Pass on Extension of TRIPS Waiver,

12/05/2023

News:

News:

C4IP Expresses Support for Anticounterfeiting Legislation Introduced in the Senate,

10/06/2023

Scroll to Top